Similar Search Results

The Changing Geography of Clinical Research : A Critical Analysis of Its Drivers

Häussler, Carolin - 2016

Research and development activities have become more and more internationalized with emerging economies playing an increasingly important role. This phenomenon is particularly debated in the pharmaceutical industry where (western‐) pharmaceutical companies have started to offshore clinical...

Persistent link: https://www.econbiz.de/10012982066

F&E-Internationalisierung von Big-Pharmaunternehmen in Schwellenländern

Fleischmann, Carolin; Kaumanns, Daniel; Thiel, Sabine - In: Internationalisierung im Gesundheitswesen : Strategien, …, (pp. 317-338). 2019

Persistent link: https://www.econbiz.de/10011961615

Big Pharma, little science? : a bibliometric perspective on Big Pharma's R&D decline

Rafols, Ismael; Hopkins, Michael M.; Hoekman, Jarno; … - In: Technological forecasting & social change : an … 81 (2014), pp. 22-38

Persistent link: https://www.econbiz.de/10010403289

Public-private and private-private collaboration as pathways for socially beneficial innovation : evidence from antimicrobial drug-development tasks

Arslan, Birgul; Vasudeva, Gurneeta; Hirsch, Elizabeth B. - In: Academy of Management journal : AMJ 67 (2024) 2, pp. 554-582

Persistent link: https://www.econbiz.de/10014546516

What are the most promising conduits for foreign knowledge inflows? : innovation networks in the Chinese pharmaceutical industry

Perri, Alessandra; Scalera, Vittoria G.; Mudambi, Ram - In: Industrial and corporate change 26 (2017) 2, pp. 333-355

Persistent link: https://www.econbiz.de/10011724545

Offshoring innovation to emerging markets : organizational control and informal institutional distance

Sartor, Michael A.; Beamish, Paul W. - In: Journal of international business studies : JIBS ; an … 45 (2014) 9, pp. 1072-1095

Persistent link: https://www.econbiz.de/10010439050

Globalisation of R&D and host-counry patenting of multinational corporations in emerging countries

Gerybadze, Alexander; Merk, Sebastian - In: International journal of technology management : IJTM 64 (2014) 2/4, pp. 148-179

Persistent link: https://www.econbiz.de/10010437215

Dual market structures and the likelihood of repeated ties - evidence from pharmaceutical biotechnology

Roijakkers, Nadine; Hagedoorn, John; Kranenburg, Hans L. van - In: Research policy : policy, management and economic … 34 (2005) 2, pp. 235-245

Persistent link: https://www.econbiz.de/10002771076

Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks

Roijakkers, Nadine; Hagedoorn, John - In: Research policy : policy, management and economic … 35 (2006) 3, pp. 431-446

Persistent link: https://www.econbiz.de/10003314626

Economic drivers of pharmaceutical investment location

Lewis, David; Bramley-Harker, Robert Edward; Farahnik, … - In: World economics : a journal of current economic … 8 (2007) 3, pp. 171-182

Persistent link: https://www.econbiz.de/10003587042